Solid Biosciences Inc.(SLDB)
Biotechnology
Gene Therapy & Gene Editing
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Cumbo Alexander President and CEO | Sale | -16,644 | -6.60%235,405 | $5.82 | $96,923 | View SEC filing | |
| 2026-02-18 | Hanrahan Jessie Chief Regulatory Officer | Sale | -4,134 | -5.27%74,318 | $5.82 | $24,074 | View SEC filing | |
| 2026-02-18 | Ganot Ilan Director | Sale | -2,658 | -8.82%27,474 | $5.82 | $15,478 | View SEC filing | |
| 2026-02-18 | Herzich Paul Chief Technology Officer | Sale | -3,616 | -4.74%72,638 | $5.82 | $21,057 | View SEC filing | |
| 2026-02-18 | Howton David T Chief Operating Officer | Sale | -7,469 | -6.64%105,077 | $5.82 | $43,494 | View SEC filing | |
| 2026-02-18 | Tan Kevin CFO & Treasurer | Sale | -5,404 | -5.16%99,422 | $5.82 | $31,469 | View SEC filing | |
| 2026-02-06 | Howton David T Chief Operating Officer | Sale | -18,894 | -16.18%97,859 | $6.44 | $121,713 | View SEC filing | |
| 2026-02-06 | Cumbo Alexander President and CEO | Sale | -48,913 | -18.05%222,018 | $6.44 | $315,093 | View SEC filing | |
| 2026-02-06 | Ganot Ilan Director | Sale | -7,205 | -22.19%25,271 | $6.44 | $46,414 | View SEC filing | |
| 2026-02-06 | Tan Kevin CFO & Treasurer | Sale | -14,783 | -13.56%94,201 | $6.44 | $95,231 | View SEC filing | |
| 2026-02-06 | Brooks Gabriel Chief Medical Officer | Sale | -12,616 | -13.05%84,092 | $6.44 | $81,271 | View SEC filing | |
| 2026-02-06 | Hanrahan Jessie Chief Regulatory Officer | Sale | -12,348 | -14.94%70,327 | $6.44 | $79,545 | View SEC filing | |
| 2026-02-06 | Herzich Paul Chief Technology Officer | Sale | -10,905 | -13.64%69,067 | $6.44 | $70,249 | View SEC filing | |
| 2026-02-02 | Tan Kevin CFO & Treasurer | Sale | -26,837 | -19.76%108,984 | $6.44 | $172,747 | View SEC filing | |
| 2026-02-02 | Cumbo Alexander President and CEO | Sale | -80,258 | -22.85%270,931 | $6.44 | $516,613 | View SEC filing | |
| 2026-02-02 | Hanrahan Jessie Chief Regulatory Officer | Sale | -26,535 | -24.30%82,675 | $6.44 | $170,803 | View SEC filing | |
| 2026-02-02 | Brooks Gabriel Chief Medical Officer | Sale | -28,335 | -22.66%96,708 | $6.44 | $182,390 | View SEC filing | |
| 2026-02-02 | Howton David T Chief Operating Officer | Sale | -37,771 | -24.44%116,753 | $6.44 | $243,128 | View SEC filing | |
| 2026-02-02 | Herzich Paul Chief Technology Officer | Sale | -26,250 | -24.71%79,972 | $6.44 | $168,969 | View SEC filing | |
| 2026-01-30 | Ganot Ilan Director | Sale | -191 | -1.08%17,476 | $6.59 | $1,259 | View SEC filing | |
| 2026-01-13 | Tan Kevin CFO & Treasurer | Sale | -5,704 | -11.01%46,100 | $5.27 | $30,060 | View SEC filing | |
| 2026-01-06 | Ganot Ilan Director | Sale | -1,053 | -5.74%17,278 | $5.43 | $5,718 | View SEC filing | |
| 2025-12-04 | Howton David T Chief Operating Officer | Sale | -4,932 | -13.03%32,908 | $5.11 | $25,203 | View SEC filing | |
| 2025-12-04 | Cumbo Alexander President and CEO | Sale | -10,808 | -11.72%81,388 | $5.11 | $55,229 | View SEC filing | |
| 2025-12-04 | Hanrahan Jessie Chief Regulatory Officer | Sale | -4,483 | -14.39%26,660 | $5.11 | $22,908 | View SEC filing |
1-25 of 100